Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Nicholson

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
European Journal of Clinical Pharmacology|January 1, 1992
Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbidopaS G Bowes, R J Dobbs, M Henley, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording deviceR Cheung, J Dickins, P W Nicholson, et al.
British Journal of Clinical Pharmacology|February 1, 1992
Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patientsC J O'Neill, A Charlett, R J Dobbs, et al.
British Journal of Clinical Pharmacology|July 1, 1990
Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapyS G Bowes, P K Clark, A L Leeman, et al.
British Journal of Clinical Pharmacology|March 1, 1991
Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesiaS G Bowes, P K Clark, A Charlett, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonismC Kirollos, A Charlett, S G Bowes, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonismC Kirollos, A Charlett, C J O'Neill, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
European Journal of Clinical Pharmacology|January 1, 1992
Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbidopaS G Bowes, R J Dobbs, M Henley, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording deviceR Cheung, J Dickins, P W Nicholson, et al.
British Journal of Clinical Pharmacology|February 1, 1992
Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patientsC J O'Neill, A Charlett, R J Dobbs, et al.
British Journal of Clinical Pharmacology|July 1, 1990
Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapyS G Bowes, P K Clark, A L Leeman, et al.
British Journal of Clinical Pharmacology|March 1, 1991
Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesiaS G Bowes, P K Clark, A Charlett, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonismC Kirollos, A Charlett, S G Bowes, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonismC Kirollos, A Charlett, C J O'Neill, et al.
Pageof 5